These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 38841300

  • 1. Case report: Strong GAD antibody positivity and type 1 diabetes-HLA-susceptible haplotype-DRB1*04:05-DQB1*04:01 in a Japanese patient with immune checkpoint inhibitor-induced type 1 diabetes.
    Yabuki S, Hirai H, Moriya C, Kusano Y, Hasegawa T.
    Front Endocrinol (Lausanne); 2024; 15():1407192. PubMed ID: 38841300
    [Abstract] [Full Text] [Related]

  • 2. Type 1 diabetes associated with immune checkpoint inhibitors for malignant melanoma: A case report and review of 8 cases.
    Ishiguro A, Ogata D, Ohashi K, Hiki K, Yamakawa K, Jinnai S, Tsutsui K, Takahashi A, Namikawa K, Yamazaki N.
    Medicine (Baltimore); 2022 Sep 02; 101(35):e30398. PubMed ID: 36107581
    [Abstract] [Full Text] [Related]

  • 3. Clinical and HLA genotype analysis of immune checkpoint inhibitor-associated diabetes mellitus: a single-center case series from China.
    Liu YC, Liu H, Zhao SL, Chen K, Jin P.
    Front Immunol; 2023 Sep 02; 14():1164120. PubMed ID: 37359544
    [Abstract] [Full Text] [Related]

  • 4. Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
    Yasui J, Kawasaki E, Tanaka S, Awata T, Ikegami H, Imagawa A, Uchigata Y, Osawa H, Kajio H, Kawabata Y, Shimada A, Takahashi K, Yasuda K, Yasuda H, Hanafusa T, Kobayashi T, Japan Diabetes Society Committee on Type 1 Diabetes Mellitus Research.
    PLoS One; 2016 Sep 02; 11(5):e0155643. PubMed ID: 27177031
    [Abstract] [Full Text] [Related]

  • 5. Amino acid polymorphisms in human histocompatibility leukocyte antigen class II and proinsulin epitope have impacts on type 1 diabetes mellitus induced by immune-checkpoint inhibitors.
    Inaba H, Morita S, Kosugi D, Asai Y, Kaido Y, Ito S, Hirobata T, Inoue G, Yamamoto Y, Jinnin M, Kimura H, Ota M, Okudaira Y, Nakatani H, Kobayashi T, Iwama S, Arima H, Matsuoka T.
    Front Immunol; 2023 Sep 02; 14():1165004. PubMed ID: 37114039
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunogenetic Study of Diabetes Mellitus in Relation to HLA DQ and DR.
    Singh G, Singh U, Singh SK, Singh S.
    Indian J Endocrinol Metab; 2020 Sep 02; 24(4):325-332. PubMed ID: 33088755
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. HLA Risk Haplotype: Insulin Deficiency in Pediatric Type 1 Diabetes.
    Gómez-Díaz RA, Nishimura-Meguro E, Garrido-Magaña E, Lizárraga-Paulin L, Aguilar-Herrera BE, Bekker-Méndez C, Medina-Santillán R, Barquera R, Mondragón-González R, Wacher NH.
    Rev Invest Clin; 2016 Sep 02; 68(3):128-36. PubMed ID: 27408999
    [Abstract] [Full Text] [Related]

  • 10. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
    El-Amir MI, El-Feky MA, Laine AP, Härkönen T, El-Badawy O, Eltayeb AA, El-Melegy TT, Kiviniemi M, Knip M, Ilonen J.
    Diabetes Metab Res Rev; 2015 Mar 02; 31(3):287-94. PubMed ID: 25256132
    [Abstract] [Full Text] [Related]

  • 11. Combined immune checkpoint inhibitor therapy with nivolumab and ipilimumab causing acute-onset type 1 diabetes mellitus following a single administration: two case reports.
    Zezza M, Kosinski C, Mekoguem C, Marino L, Chtioui H, Pitteloud N, Lamine F.
    BMC Endocr Disord; 2019 Dec 23; 19(1):144. PubMed ID: 31870373
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.
    Godwin JL, Jaggi S, Sirisena I, Sharda P, Rao AD, Mehra R, Veloski C.
    J Immunother Cancer; 2017 Dec 23; 5():40. PubMed ID: 28515940
    [Abstract] [Full Text] [Related]

  • 15. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic mucosal melanoma.
    Goff CB, Plaxe SC, White W, Dasanu CA.
    J Oncol Pharm Pract; 2023 Jul 23; 29(5):1259-1263. PubMed ID: 36734125
    [Abstract] [Full Text] [Related]

  • 16. Case of slowly progressive type 1 diabetes mellitus with drastically reduced insulin secretory capacity after immune checkpoint inhibitor treatment for advanced renal cell carcinoma.
    Yamaguchi H, Miyoshi Y, Uehara Y, Fujii K, Nagata S, Obata Y, Kosugi M, Hazama Y, Yasuda T.
    Diabetol Int; 2021 Apr 23; 12(2):234-240. PubMed ID: 33786278
    [Abstract] [Full Text] [Related]

  • 17. Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies.
    Petrone A, Battelino T, Krzisnik C, Bugawan T, Erlich H, Di Mario U, Pozzilli P, Buzzetti R.
    Tissue Antigens; 2002 Sep 23; 60(3):244-53. PubMed ID: 12445307
    [Abstract] [Full Text] [Related]

  • 18. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
    Ishii M, Hasegawa G, Fukui M, Obayashi H, Ohta M, Ogata M, Yoshioka K, Kitagawa Y, Nakano K, Yoshikawa T, Nakamura N.
    Immunol Lett; 2005 Jul 15; 99(2):180-5. PubMed ID: 16009268
    [Abstract] [Full Text] [Related]

  • 19. HLA-associated phenotypes in youth with autoimmune diabetes.
    Black MH, Lawrence JM, Pihoker C, Dolan LM, Anderson A, Rodriguez B, Marcovina SM, Mayer-Davis EJ, Imperatore G, Dabelea D, SEARCH for Diabetes in Youth Study Group.
    Pediatr Diabetes; 2013 Mar 15; 14(2):121-8. PubMed ID: 22913598
    [Abstract] [Full Text] [Related]

  • 20. Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese.
    Zheng C, Zhou Z, Yang L, Lin J, Huang G, Li X, Zhou W, Wang X, Liu Z.
    Diabetes Metab Res Rev; 2011 Jan 15; 27(1):70-8. PubMed ID: 21218510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.